Next Generation Genome Editing Market Size, Share & Trends Analysis Distribution by Type of Gene Editing Technique (Recombinase-Based Editing, Prime Genome Editing, Bridge Editing, Base Editing, Retron Library Recombineering (RLR), Transposon-Based Systems, Homology-Directed Repair (HDR)), Application Area, Type of End User and Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Next Generation Genome Editing Market Snapshot Chapter 4. Global Next Generation Genome Editing Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Type of Gene Editing Technique Estimates & Trend Analysis 5.1. By Type of Gene Editing Technique & Market Share, 2023 & 2031 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Gene Editing Technique: 5.2.1. Recombinase-Based Editing 5.2.2. Prime Genome Editing 5.2.3. Bridge Editing 5.2.4. Base Editing 5.2.5. Retron Library Recombineering (RLR) 5.2.6. Transposon-Based Systems 5.2.7. Homology-Directed Repair (HDR) 5.2.8. Other emerging technologies Chapter 6. Market Segmentation 2: By Application Area Estimates & Trend Analysis 6.1. By Application Area & Market Share, 2023 & 2031 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application Area: 6.2.1. Drug Discovery and Development 6.2.2. Diagnostics Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis 7.1. By End User & Market Share, 2023 & 2031 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User: 7.2.1. Biotechnology Companies 7.2.2. Academic Institutions 7.2.3. Government Laboratories 7.2.4. Contract Research Organizations Chapter 8. Next Generation Genome Editing Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031 8.1.2. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031 8.1.3. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.1.4. North America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.2. Europe 8.2.1. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031 8.2.2. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031 8.2.3. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.2.4. Europe Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.3. Asia Pacific 8.3.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031 8.3.2. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031 8.3.3. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.3.4. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.4. Latin America 8.4.1. Asia Pacific Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031 8.4.2. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031 8.4.3. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.4.4. Latin America Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.5. Middle East & Africa 8.5.1. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Type of Gene Editing Technique, 2024-2031 8.5.2. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2024-2031 8.5.3. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.5.4. Middle East & Africa Next Generation Genome Editing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Addgene 9.2.2. Beam Therapeutics 9.2.3. Bio Palette Co., Ltd 9.2.4. Caribou Biosciences 9.2.5. Cellectis 9.2.6. Creative Biogene 9.2.7. CRISPR Therapeutics. 9.2.8. Danaher Corporation 9.2.9. EdiGene, Inc. 9.2.10. Editas Medicine 9.2.11. ElevateBio 9.2.12. GenKOre 9.2.13. GenScript 9.2.14. Horizon Discovery Ltd. 9.2.15. Inscripta, Inc 9.2.16. Integrated DNA Technologies (IDT) 9.2.17. Intellia Therapeutics 9.2.18. KromaTiD, Inc 9.2.19. Maravai LifeSciences 9.2.20. Merck KGaA 9.2.21. Pairwise 9.2.22. Precision BioSciences 9.2.23. ProQR Therapeutics 9.2.24. QI-Biodesign 9.2.25. Recombinetics 9.2.26. Revvity 9.2.27. Sangamo Therapeutics, Inc. 9.2.28. Scribe Therapeutics 9.2.29. Shape TX 9.2.30. Synthego 9.2.31. Synthorx (part of Sanofi) 9.2.32. Other prominent players